Capricor Therapeutics (CAPR)
(Delayed Data from NSDQ)
$5.01 USD
-0.04 (-0.79%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $5.00 -0.01 (-0.20%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth B Momentum F VGM
Cash flow Statements
Fiscal Year End for Capricor Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -22.29 | -29.02 | -20.02 | -13.66 | -7.64 |
Depreciation/Amortization & Depletion | 1.07 | 0.53 | 0.25 | 0.14 | 0.17 |
Net Change from Assets/Liabilities | -11.75 | 28.75 | 0.18 | 1.51 | -0.06 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 7.37 | 4.65 | 2.79 | 1.95 | 0.70 |
Net Cash From Operating Activities | -25.60 | 4.92 | -16.81 | -10.05 | -6.82 |
Property & Equipment | -2.05 | -3.36 | -1.20 | -0.55 | 3.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 7.16 | -31.71 | 0.00 | 5.99 | -6.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 5.11 | -35.07 | -1.20 | 5.44 | -3.00 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 25.58 | 4.87 | 20.23 | 33.06 | 9.18 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.32 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 25.58 | 4.87 | 20.23 | 33.38 | 9.18 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 5.09 | -25.28 | 2.22 | 28.77 | -0.65 |
Cash at Beginning of Period | 9.60 | 34.89 | 32.67 | 3.90 | 4.55 |
Cash at End of Period | 14.69 | 9.60 | 34.89 | 32.67 | 3.90 |
Diluted Net EPS | -0.83 | -1.18 | -0.87 | -0.88 | -2.06 |
Fiscal Year End for Capricor Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -22.29 | -21.53 | -15.13 | -7.77 |
Depreciation/Amortization & Depletion | NA | 1.07 | 0.76 | 0.48 | 0.23 |
Net Change from Assets/Liabilities | NA | -11.75 | 1.24 | 5.63 | 9.55 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 7.37 | 5.52 | 3.81 | 2.19 |
Net Cash From Operating Activities | NA | -25.60 | -14.00 | -5.21 | 4.21 |
Property & Equipment | NA | -2.05 | -1.32 | -0.69 | -0.45 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 7.16 | 12.29 | 3.94 | -2.76 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | 5.11 | 10.97 | 3.25 | -3.21 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 25.58 | 2.41 | 2.19 | 0.00 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 25.58 | 2.41 | 2.19 | 0.00 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | 5.09 | -0.62 | 0.23 | 1.00 |
Cash at Beginning of Period | NA | 9.60 | 9.60 | 9.60 | 9.60 |
Cash at End of Period | NA | 14.69 | 8.98 | 9.84 | 10.61 |
Diluted Net EPS | NA | 0.02 | -0.25 | -0.29 | -0.31 |